发明名称 PYRROLOPYRAMIDINES, WITH INHIBITING PROPERTIES TO CATEPSIN K AND METHOD OF OBTAINING THEM (VERSIONS)
摘要 FIELD: chemistry, pharmaceuticals. ^ SUBSTANCE: invention pertains to new compounds with formula I, their pharmaceutical salts and to complex esters. The invented compounds have inhibiting propertied towards catepsin K and can be used for making medicinal preparations for curing diseases and conditions, in which catepsin K is involved, for example, inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumorous diseases. In general formula I R represents H, R13 represents (inferior)alkyl, C3-C10cylcloalkyl or C3-C10cycloalkyl(inferior)alkyl, each of which is independently optionally substituted with a halogen atom, hydroxyl, CN, NO2 or optionally mono- or di(inferior)alkyl substituted amino group; and R14 represents H or optionally substituted phenyl, phenyl-W-, phenyl(inferior)alkyl-W-, C3-C10cycloalkyl, C3-C10cycloalkyl-W-, N-heterocyclyl, N-heterocyclyl -W-. Substitutes of the indicated values of radicals are shown in the formula of invention. The invention also relates to methods of obtaining the compounds. ^ EFFECT: obtaining pyrrolopyrimidines with inhibiting properties towards catepsin K, which can be used for making medicinal preparations for curing diseases and conditions, in which catepsin K is involved. ^ 4 cl, 59 tbl, 10 ex
申请公布号 RU2331644(C2) 申请公布日期 2008.08.20
申请号 RU20040109815 申请日期 2002.08.29
申请人 NOVARTIS AG 发明人 BETSHART KLAUDIA;KHAJAKAVA KENDZHI;IRIE OSAMU;SAKAKI JUNICHI;IVASAKI GENDZHI;LATTMANN RENE;MISSBAKH MARTIN;TENO NAOKI
分类号 C07D487/04;A61K31/519;A61K31/5365;A61K31/5377;A61K31/551;A61P9/00;A61P9/10;A61P11/00;A61P19/02;A61P19/10;A61P29/00;A61P31/00;A61P35/00;A61P35/04;A61P37/02;A61P37/06;A61P43/00;C07D473/00;C07D491/107;C07D495/10;C07D498/10;C07D519/00 主分类号 C07D487/04
代理机构 代理人
主权项
地址